BYRNES ROBERT F

CIK 00012631752 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001263175

Recent Transactions

23 trades

Award
Revance Therapeutics, Inc.
Common Stock
2020-05-14+6,000→ 16,500 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2020-05-14+12,000→ 12,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2019-05-09+4,500→ 10,500 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2019-05-09+9,000→ 9,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2018-05-10+6,000→ 6,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2018-05-10+3,000→ 6,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2017-05-11+3,000→ 3,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2017-05-11+6,000→ 6,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2016-05-05+8,000→ 8,000 total
Gift
Revance Therapeutics, Inc.
Common Stock
2016-02-24+10,999→ 13,665 total
Gift
Revance Therapeutics, Inc.
Common Stock
2016-02-24−10,999→ 0 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2016-02-12$6.60/sh+4,000→ 4,000 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2016-02-12−1,666→ 0 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2016-02-12−5,333→ 0 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2016-02-12−4,000→ 0 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2016-02-12$2.55/sh+1,666→ 5,666 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2016-02-12$2.55/sh+5,333→ 10,999 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2015-05-07+8,000→ 8,000 total
Gift
Revance Therapeutics, Inc.
Common Stock
2014-09-17−2,666→ 0 total
Exercise/Conversion
Revance Therapeutics, Inc.
Common Stock
2014-09-17$3.60/sh+2,666→ 2,666 total
Gift
Revance Therapeutics, Inc.
Common Stock
2014-09-17+2,666→ 2,666 total
Exercise/Conversion
Revance Therapeutics, Inc.
Stock Option (Right to Buy)
2014-09-17−2,666→ 0 total
Award
ENDOCARE INC
Stock Option (Right to Buy)
2004-01-02+5,000→ 5,000 total

Companies

Recent Filings

Address

C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD

NEWARK, CA, 94560

View on SEC.gov